- Home
- APLD vs VRDN Comparison
APLD vs VRDN Comparison
Compare APLD & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLD
- VRDN
- Stock Information
- Founded
- APLD 2001
- VRDN 2006
- Country
- APLD United States
- VRDN United States
- Employees
- APLD N/A
- VRDN N/A
- Industry
- APLD Investment Bankers/Brokers/Service
- VRDN Medical Specialities
- Sector
- APLD Finance
- VRDN Health Care
- Exchange
- APLD Nasdaq
- VRDN Nasdaq
- Market Cap
- APLD 1.3B
- VRDN 1.3B
- IPO Year
- APLD N/A
- VRDN N/A
- Fundamental
- Price
- APLD $9.18
- VRDN $17.08
- Analyst Decision
- APLD Strong Buy
- VRDN Strong Buy
- Analyst Count
- APLD 11
- VRDN 11
- Target Price
- APLD $12.64
- VRDN $38.50
- AVG Volume (30 Days)
- APLD 36.3M
- VRDN 791.2K
- Earning Date
- APLD 08-27-2025
- VRDN 08-07-2025
- Dividend Yield
- APLD N/A
- VRDN N/A
- EPS Growth
- APLD N/A
- VRDN N/A
- EPS
- APLD N/A
- VRDN N/A
- Revenue
- APLD $221,192,000.00
- VRDN $302,000.00
- Revenue This Year
- APLD $34.51
- VRDN N/A
- Revenue Next Year
- APLD $3.33
- VRDN $17,102.33
- P/E Ratio
- APLD N/A
- VRDN N/A
- Revenue Growth
- APLD 53.70
- VRDN 4.86
- 52 Week Low
- APLD $3.01
- VRDN $9.90
- 52 Week High
- APLD $15.42
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- APLD 45.01
- VRDN 71.45
- Support Level
- APLD $9.13
- VRDN $13.84
- Resistance Level
- APLD $9.64
- VRDN $17.53
- Average True Range (ATR)
- APLD 0.69
- VRDN 0.79
- MACD
- APLD -0.29
- VRDN 0.22
- Stochastic Oscillator
- APLD 8.25
- VRDN 87.80
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments; Data Center Hosting Business, Cloud Services Business, and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business which operates data centers to provide energized space to crypto mining customers.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).